Position history for UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's holdings in NEUROCRINE BIOSCIENCES INC
UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC holds 722,476 shares of NBIX (NEUROCRINE BIOSCIENCES INC), worth $102.5M as of 2025-Q4. The position was decreased (-5.6% shares). NBIX represents 0.0% of UBS AM, a distinct business unit of UBS ASSET MANAGEMENT AMERICAS LLC's portfolio.
Current Value
$102.5M
Current Shares
722,476
Total Value Change
-$23.1M
Total Shares Change
-189,588
Other major holders of NBIX: BNP PARIBAS FINANCIAL MARKETS, DnB Asset Management AS
Decreased |
| 722,476 |
-5.6% |
| $102.5M |
| 0.0% |
| $140.95 |
0 |
| 2025-Q3 | Decreased | 765,237 | -44.9% | $107.4M | 0.0% | $140.27 | 0 |
| 2025-Q2 | Increased | 1.4M | +19.7% | $174.4M | 0.0% | $125.42 | 36 |
| 2025-Q1 | Increased | 1.2M | +8.3% | $128.2M | 0.0% | $113.16 | 33 |
| 2024-Q4 | Increased | 1.1M | +19.7% | $146.1M | 0.0% | $137.06 | 36 |
| 2024-Q3 | Decreased | 894,217 | -2.0% | $103M | 0.0% | $115.06 | 0 |
| 2024-Q2 | Increased | 912,064 | +52.2% | $125.6M | 0.0% | $137.67 | 42 |